| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213950 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 38 Pages |
Abstract
IMRT BMS plans reduced the dose to FLT-identified pelvic bone marrow for pelvic cancer patients. However, reducing hematologic toxicity is challenging owing to the acute radiation sensitivity (â¼4Â Gy) and chronic suppression of activity in bone marrow receiving radiation doses >35Â Gy, as measured by the FLT uptake change correlated with the complete blood cell counts.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
![Using [18F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients](/preview/png/8213950.png "First Page Preview: Using [18F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients")
Authors
Sarah M. PhD, Sudershan K. MD, Wenqing MD, Geraldine M. MD, MPH, MBA, Yusuf MD, Laura L. PhD, Brian J. PhD, Brandie A. CMD, John E. PhD, John J. PhD, Michael M. MD, PhD, John M. MD,